Universities and research institutes at Antibody Engineering 2026

Dec 13–16, 2026 San Diego, CA ~900 attendees Website

24 universities and research institutes are at Antibody Engineering 2026 — 30 presentations on the program. Most represented: University of Southampton (3 on the program), City of Hope (2 on the program), Harvard University (2 on the program). 5 of them have their own page in this guide. As of Sep 26, 2026.

All 153 organizations at Antibody Engineering 2026 →

Showing 1–18 of 24 organizations

Organization	Antibody Engineering 2026 Attendance
University of Southampton Southampton, United Kingdom
southampton.ac.uk Academic Public research university whose Centre for Cancer Immunology works on antibody immunotherapy and Fc receptor biology.	Talk Mon Dec 14 2:25pm–2:30pm Co-Chairs’ Remarks Track 2: Engineering Solutions for Accessing Difficult Targets · with Macaw Therapeutics Talk Mon Dec 14 4:45pm–5:15pm Disulfide Engineering of Immunostimulatory Antibodies for Augmented Receptor Agonism and Immune Cell Stimulation Adding chemical bridges between an antibody's two arms to lock its shape and make it switch on immune cells more strongly. Protein engineering Talk Tue Dec 15 8:10am–8:15am Co-Chairs' Remarks Track 2: Antibody Engineering for Proximity-Based Approaches · with Chai Discovery
City of Hope Duarte, CA
cityofhope.org Academic Cancer research and treatment center with a graduate school.	Talk Wed Dec 16 3:15pm–3:45pm MPACT: Engineering the Fc–FcγR Interface for Plug-and-Play, Mixed-Valency Multispecific Antibodies Using a chemical bond at a natural antibody contact point to snap extra targeting or immune-activating parts onto one antibody. Bispecifics & multispecifics Talk Wed Dec 16 4:15pm–4:45pm Turning up the Heat: Radioimmunoconjugates for Targeted Radiation Therapy Using antibodies and smaller antibody pieces to carry radioactive atoms that both image and irradiate tumors.
Harvard University Cambridge, MA
harvard.edu Academic Private research university, including Harvard Medical School.	Talk Mon Dec 14 2:30pm–3:00pm Discovery of G protein-coupled Receptor Modulator Antibody Fragments Small antibody fragments that switch on or block the large family of signal-receiving proteins in cell membranes. Protein engineering Talk Wed Dec 16 8:15am–8:45am A New Homotypic Interface Expands Anti-Malarial Antibody Recognition Breadth Evolving a malaria antibody so copies of it grip each other in a new way and protect against more parasite strains. Beyond oncology
University of Michigan Ann Arbor, MI
umich.edu Academic Public research university in Ann Arbor, Michigan.	Talk Sun Dec 13 1:00pm–1:15pm Co-Chairs’ Remarks- Engineering Considerations for Candidate Selection and Developability Workshop 2: Engineering Considerations for Candidate Selection and Developability · with Atlas Venture NewCo Talk Tue Dec 15 3:00pm–3:30pm Dual-targeted Oligoshuttles Mediate Efficient Reduction of Neuronal Gene Expression after Peripheral Administration Antibodies that grab two receptors to cross into the brain and deliver gene-silencing strands into nerve cells. Bispecifics & multispecifics
University of Texas at Austin Austin, TX
utexas.edu Academic Public research university in Austin, Texas.	Talk Mon Dec 14 5:15pm–5:45pm Computational Approaches for Antibody and TCR Modeling Design and Discovery Track 1: Emerging In Vitro Approaches to Antibody Discovery AI & computational design Talk Tue Dec 15 10:30am–11:00am Utilizing Repertoire Mining to Complement In Vivo Antibody Discovery for Antibody Therapeutics Track 1: Advanced In Vivo Approaches to Antibody Discovery
Beth Israel Deaconess Medical Center Boston, MA
bidmc.org Academic Harvard Medical School teaching hospital in Boston.	Talk Tue Dec 15 4:45pm–5:15pm High-throughput Engineering of Bispecific Antibodies to Stimulate Macrophage-mediated Destruction of B-cell Lymphoma Screening many two-target antibodies to find which best push macrophages, the immune cells that engulf debris, to eat lymphoma cells.
Dana-Farber Cancer Institute Boston, MA
dana-farber.org Academic Harvard Medical School-affiliated cancer research and treatment center in Boston.	Talk Mon Dec 14 10:55am–11:30am Jim Huston Science Talent Award and Presentation: Keynote Presentations - Livestream · with Xencor
Emory University Atlanta, GA
emory.edu Academic Private research university with a medical school in Atlanta.	Talk Mon Dec 14 4:45pm–5:15pm Biology of Human Plasma Cells at a Single-Cell Level Keeping human antibody-secreting cells alive in a lab-grown bone marrow model long enough to learn what they recognize. Antibody discovery
Max Planck Institute of Biochemistry Martinsried, Germany
biochem.mpg.de Academic Max Planck Society research institute studying protein structure and function.	Talk Wed Dec 16 11:00am–11:30am How Nanoscale Spatial Organization Determines Therapeutic Antibody Function A way to see antibodies and their receptors in three dimensions on intact cells, showing how their arrangement shapes antibody function.
Memorial Sloan Kettering Cancer Center New York, NY
mskcc.org Academic Cancer treatment and research center in New York City.	Talk Wed Dec 16 3:15pm–3:45pm DLL3 Antibody-Based Radiotheranostics: From ImmunoPET to Targeted Radioligand Therapy Antibodies carrying radioactive tags to both image and treat neuroendocrine tumors, and to pick the patients likely to respond.
MIT Cambridge, MA
mit.edu Academic Massachusetts Institute of Technology, a private research university.	Talk Mon Dec 14 2:25pm–2:30pm Co-Chairs' Remarks Track 1: Emerging In Vitro Approaches to Antibody Discovery · with Stony Brook University
Ragon Institute of MGH, MIT and Harvard Cambridge, MA
ragoninstitute.org Academic Immunology research institute of Massachusetts General Hospital, MIT and Harvard working on vaccines and infectious diseases.	Keynote Mon Dec 14 8:05am–8:40am Evolving Novel Biologics In Vivo How genetically engineered mice can harness natural antibody evolution to improve known antibodies and uncover entirely new ones. Antibody discovery
Seoul National University Seoul, South Korea
snu.ac.kr Academic National research university in Seoul, South Korea.	Talk Wed Dec 16 4:45pm–5:15pm Expanding the Fc Functional Spectrum: A Diverse Repertoire of Novel Fc Variants for Enhanced Potency, Complete Effector Silencing, Extended Persistence, and Accelerated Pathogenic IgG Clearance Engineered versions of the antibody tail that strengthen cell killing, switch it off, lengthen time in the blood, or clear harmful self-antibodies.
Stevens Institute of Technology Hoboken, NJ
stevens.edu Academic Private technological university in Hoboken, New Jersey.	Talk Sun Dec 13 3:15pm–3:45pm Hybrid Molecular Modeling and Machine Learning for Screening Viscosity-Reducing Excipients in Antibody Formulations Combining physics-based models with machine learning to find additives that keep concentrated antibody solutions from becoming too thick. AI & computational design
Stony Brook University Stony Brook, NY
stonybrook.edu Academic Public research university in the State University of New York system.	Talk Mon Dec 14 2:25pm–2:30pm Co-Chairs' Remarks Track 1: Emerging In Vitro Approaches to Antibody Discovery · with MIT
Technical University of Denmark Kongens Lyngby, Denmark
dtu.dk Academic Danish technical university with research spanning engineering, biotechnology and health technology.	Keynote Mon Dec 14 8:40am–9:15am Snakebite Antivenoms En Route to Recombinant Biologics? How laboratory-made antibodies could replace plasma-derived antivenoms for snakebite, and what still blocks their use in patients. Antibody discoveryBeyond oncology
The Hospital for Sick Children (SickKids) Toronto, Canada
sickkids.ca Academic Pediatric teaching hospital and research institute affiliated with the University of Toronto.	Talk Tue Dec 15 3:30pm–4:00pm Translating Multivalent Antibody Designs into Potent Viral Neutralizers Combining several antibodies into one molecule to neutralize varied viruses such as HIV, and what that does to blood levels. Bispecifics & multispecifics
UCSF San Francisco, CA
ucsf.edu Academic University of California health sciences campus in San Francisco focused on biomedical research and medicine.	Talk Tue Dec 15 9:15am–9:45am Engineering and Characterization of Novel CD19 Antibodies to Control B Cell Activation Two new antibodies that bind different spots on a key B-cell receptor and change how strongly those cells signal. Beyond oncology